Tang, L. , Yang, W. and Wang, Q. (2025) Case Analysis and Management Strategies of Glucocorticoid-Induced Metabolic Syndrome during Pregnancy. Journal of Biosciences and Medicines, 13, 39-45. doi: ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...

Phase 1 results disclosed Monday indicate the company’s protein-degrading drug can affect a tough-to-reach target called STAT6 that’s implicated in many autoimmune conditions.

Pasritamig, a first-in-class bispecific T-cell-engaging antibody, shows potential in mCRPC with outpatient dosing designed for the community setting ...

DNA methylation, RTK pathway changes, and KRAS amplifications may drive resistance to sotorasib plus panitumumab in KRAS G12C ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of ...

Curcumin, a phenolic antioxidant extracted from the rhizomes of turmeric and other Curcuma species, possesses strong ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced that the results from the open label Phase 2 PROSPECT Study of tirabrutinib is to be ...

After 24 h, cells were intervened with different concentrations (0, 15, and 30 μM) of AKBA solution and continued ... its anti-PCa effects by inhibiting the expression of the IL-17 signaling pathway.

Detailed price information for Aclaris Therapts (ACRS-Q) from The Globe and Mail including charting and trades.